Cancer Patients Need a Cure and the Best Care Now
For the more than 1.6 million Americans diagnosed with cancer every year, the best outcomes will depend on access to the latest treatments. Since the 1970s, five-year survival rates across all cancers have jumped from 49 to 68 percent because of innovations in care—the result of groundbreaking laboratory and clinical research. But a steady decline in federal research dollars means that crucial questions about how to eradicate cancer remain unanswered.
With Your Help, We’re Making a Difference
Our Laura and Isaac Perlmutter Cancer Center is one of the few institutions in the Northeast designated a National Cancer Institute cancer center, and our faculty and staff are poised to make great strides in research and care.
In an unprecedented partnership, we’re collaborating with the Technion-Israel Institute of Technology on numerous cancer research projects. This global alliance will translate into enhanced detection, diagnosis, and treatment for oncology patients everywhere.
We’re also focused on transforming lives today. More than 18 percent of our patients participate in therapeutic clinical trials and research studies—exceeding the national average of 4 percent—and, because of our new Cancer Clinical Trials Office, that number is steadily increasing. Clinical trials fast-track innovations from bench to bedside, while making sure everyone we care for has access to the most promising medical advances now.